You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adoptive T Cell Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV specific adoptive t-cells
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 26, 2022

Viral Infection After HSCT Trial (Virus -specific T cells)

Not yet recruiting
  • Viral Infection After HSCT
  • Virus -specific T cells
  • (no location specified)
Mar 28, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Soft Tissue Sarcoma Trial in Copenhagen (LTX-315 and TILs)

Active, not recruiting
  • Soft Tissue Sarcoma
  • LTX-315 and TILs
  • Copenhagen, Denmark
    Herlev Hospital
Aug 27, 2021

Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)

Recruiting
  • Acute Myeloid Leukemia in Children
  • CIML NK Cell Infusion
  • CD3+ T Cell Product Infusion
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Peripheral Blood Mononuclear Cells From Healthy People for

Recruiting
  • Healthy Volunteer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

    Recruiting
    • HNSCC
    • +5 more
    • DP CD8 TIL
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 5, 2023

    Ovarian Cancer Recurrent Trial in Leiden (Tumor Infiltrating Lymphocytes (TIL), Interferon Alfa 2A, Carboplatin)

    Recruiting
    • Ovarian Cancer Recurrent
    • Tumor Infiltrating Lymphocytes (TIL)
    • +3 more
    • Leiden, ZH, Netherlands
      Leiden University Medical Center
    Mar 30, 2021

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

    Active, not recruiting
    Has Results
    • Medulloblastoma
    • Neuroectodermal Tumor
    • TTRNA-xALT
    • TTRNA-DCs
    • Los Angeles, California
    • +2 more
    Jan 7, 2022

    Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

    Terminated
    Has Results
    • Merkel Cell Polyomavirus Infection
    • Stage IV Merkel Cell Carcinoma AJCC v7
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 25, 2022

    Melanoma, Melanoma, Uveal, Head Neck Cancer Trial in Rotterdam (Adoptive therapy with autologous MC2 TCR T cells)

    Recruiting
    • Melanoma
    • +2 more
    • Adoptive therapy with autologous MC2 TCR T cells
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Jun 1, 2022

    Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

    Recruiting
    • Lymphoma, T-Cell, Peripheral
    • +4 more
    • MT-101
    • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
    • Duarte, California
    • +8 more
    Jan 27, 2023

    CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))

    Active, not recruiting
    • CD 19+ Acute Leukemia
    • T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 22, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

    Terminated
    Has Results
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +12 more
    • Laboratory Biomarker Analysis
    • ROR1 CAR-specific Autologous T-Lymphocytes
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2022

    Glioblastoma Multiforme Trial in Shanghai (TIL, PD1-TIL)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Shanghai, Shanghai, China
      Huashan hospital, Fudan University
    Aug 24, 2021

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

    Active, not recruiting
    • B Cell Leukemia
    • Autologous CD19 CAR+ EGFTt + T cells
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)

    Active, not recruiting
    • Leukemia
    • Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

    Recruiting
    • Pancreatic Cancer
    • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
    • Shanghai, China
      Changhai Hospital affiliated to Naval Medical University
    Mar 13, 2023

    Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

    Recruiting
    • Lymphoma
    • +2 more
    • Kappa CD28 T cells
    • Houston, Texas
    • +1 more
    Jan 31, 2022

    Tumors Trial in Gainesville, Waterloo, Springfield (Screening Platform)

    Terminated
    • Neoplasms
    • Screening Platform
    • Gainesville, Florida
    • +2 more
    Dec 1, 2022

    Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)

    Recruiting
    • Leukemia
    • Lymphoma
    • Patient-derived CD19- and CD22 specific CAR
    • Los Angeles, California
    • +4 more
    Apr 2, 2022

    Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

    Not yet recruiting
    • Lupus Nephritis
    • Type 1 Diabetes Mellitus
    • autologous adoptive T regulatory cell transfer.
    • Cairo, Egypt
      Ain shams university, faculty of medicine
    Sep 30, 2022